News

Government pushes ahead with plan for cheaper drugs deal for NHS

BMJ 2007; 335 doi: 10.1136/bmj.39300.405822.DB (Published 9 August 2007)
Cite this as: BMJ 2007;335:273.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Nicholas Timmins, public policy editor, Financial Times

    Ministers want to switch the way the NHS pays for the £8bn (€12bn; $16bn) worth of branded drugs that it buys each year. They want to move to a system in which drug prices are based on the benefits they bring to patients—and it seems they want to do so quickly.

    The radical move comes after a report from the Office of Fair Trading (OFT) in February that recommended such a shift from 2010, when the current 50 year old pharmaceutical price regulation scheme (PPRS) becomes due for its five yearly renewal (BMJ 2007;334:383 doi: 10.1136/bmj.39133.543438.DB) .

    The industry had been expecting a response but not last …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular